These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10634224)

  • 41. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Probiotics have a limited role in the treatment of inflammatory bowel disease].
    Dieleman L; Hoentjen F
    Ned Tijdschr Geneeskd; 2012; 156(40):A5206. PubMed ID: 23031240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical utility of probiotics in inflammatory bowel disease.
    Cain AM; Karpa KD
    Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Probiotics and immune regulation of inflammatory bowel diseases.
    Cong Y; Konrad A; Iqbal N; Elson CO
    Curr Drug Targets Inflamm Allergy; 2003 Jun; 2(2):145-54. PubMed ID: 14561167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K; Quigley EM
    Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
    Gassull MA
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():90-5. PubMed ID: 16961752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Probiotics in Inflammatory Bowel Disease.
    Abraham BP; Quigley EMM
    Gastroenterol Clin North Am; 2017 Dec; 46(4):769-782. PubMed ID: 29173520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
    Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
    Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases.
    Chapman TM; Plosker GL; Figgitt DP
    BioDrugs; 2007; 21(1):61-3. PubMed ID: 17263590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Probiotics and prebiotics for the treatment of inflammatory bowel disease].
    Mitsuyama K
    Nihon Rinsho; 2005 May; 63(5):850-8. PubMed ID: 15881181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preventing bacteria-induced disease with bacteria.
    Matarese LE; Kandil HM
    Nutr Clin Pract; 2012 Apr; 27(2):242-6. PubMed ID: 22378800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The current place of probiotics and prebiotics in the treatment of pouchitis.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):73-80. PubMed ID: 27048898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
    Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
    World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?
    Cary VA; Boullata J
    J Clin Nurs; 2010 Apr; 19(7-8):904-16. PubMed ID: 20492035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Probiotics in experimental and human inflammatory bowel disease: discussion points.
    Pagnini C; Cominelli F
    Dig Liver Dis; 2006 Dec; 38 Suppl 2():S270-3. PubMed ID: 17259089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis.
    Amit-Romach E; Uni Z; Reifen R
    Dis Colon Rectum; 2008 Dec; 51(12):1828-36. PubMed ID: 18633675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microecology as a target for therapeutic intervention in inflammatory bowel disease.
    Guarner F
    IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review article: antibiotics and probiotics in inflammatory bowel disease.
    Kruis W
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():75-8. PubMed ID: 15352898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probiotics in the Treatment of Inflammatory Bowel Disease.
    Guandalini S; Sansotta N
    Adv Exp Med Biol; 2019; 1125():101-107. PubMed ID: 30632114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome.
    Haller D; Antoine JM; Bengmark S; Enck P; Rijkers GT; Lenoir-Wijnkoop I
    J Nutr; 2010 Mar; 140(3):690S-7S. PubMed ID: 20107148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.